Business Wire

NY-IWBI

5.2.2020 22:09:05 CET | Business Wire | Press release

Share
WELL Hits Major Global Milestone Supporting Healthier People and Better Buildings

The International WELL Building Institute (IWBI) announced today that it has passed the 500-million-square-foot mark of buildings registered and certified under the WELL Building Standard (WELL). The milestone quickly follows this month’s earlier announcement that the number of WELL Accredited Professionals (APs) and registrants has exceeded 10,000, further evidence of the accelerating growth of the global movement to help people thrive through better buildings and communities and stronger organizations.

“With more than 4,000 projects in nearly 60 countries and spanning all space types – offices, schools, hotels, residences and more – it’s clear that this second wave of sustainability has gathered powerful momentum,” said IWBI Chairman and CEO Rick Fedrizzi. “To reach a half-billion square feet of spaces applying WELL is to positively impact the health and well-being of more people in more places and to begin to truly change the narrative around how we design and operate the spaces where we spend our time.

“So much of WELL’s success is due to our WELL APs and WELL Faculty, an active and growing community that brings education about WELL to colleagues and clients around the world,” he continued. “Together with the market reach of our 130+ organizational members, this combined leadership has played a critical role in IWBI’s journey towards market transformation, one that puts the people we care about squarely in the center of every decision we make.”

Over the course of 2019, nearly four times as many new projects registered to pursue WELL as throughout all of 2018.

“Halfway to a billion is one thing, but what’s truly remarkable is the pace of adoption,” said Rachel Gutter, President of IWBI. “WELL entered the market in 2014, and it took roughly four years to reach 250 million square feet, but it’s only taken a year to double that to a half-billion. While that’s a potent market signal, it really reflects an unbelievable rise of a dedicated community around the world that is committed to investing in health.”

To build upon this growth and momentum, IWBI also has leveraged new partnership opportunities to reach priority markets and scale the benefits of delivering better buildings.

“We are fostering a global movement to radically transform how we deliver on the promise of better buildings that help all people thrive,” said Gutter. “We know we can’t do it alone. That’s why last year we announced a partnership with Enterprise Community Partners to bridge sustainability and health by integrating WELL with the Enterprise 2020 Green Communities Criteria, which is the leading building standard for green affordable housing construction nationwide.” Currently 27 states and Washington D.C. require or incentivize Enterprise Green Communities certification for affordable housing developments that receive public funds. Beginning in October projects meeting these requirements will also be certified to WELL.

“As we continue to scale across every dimension, it becomes more important than ever that we find a place and time for our community to experience the power of this movement,” said Fedrizzi. “That’s why in two short months, we’ll convene in Scottsdale, Arizona, for the launch of The WELL Conference , a gathering designed to inspire, energize and celebrate the people and organizations who are helping us change the world.”

In collaboration with the American Society of Interior Designers (ASID) and Emerald Expositions (Emerald), The WELL Conference will bring together architectural, design and engineering communities, along with real estate developers, corporate officials, public health practitioners, and technology companies. Centered on the idea that our buildings and communities are fundamental to our health and well-being, the event will unite a diverse representation of industries and sectors around a shared mission.

“Given these enormous accomplishments in just the five years since WELL first launched, we’re beyond excited to see what this new decade will bring,” said Fedrizzi. “Every new project, WELL AP, WELL Faculty and IWBI member helps us take more steps forward in this journey. And when the mission is to improve the health of people, every milestone is worth celebrating.”

About the International WELL Building Institute

The International WELL Building Institute (IWBI) is leading the global movement to transform our buildings, communities and organizations in ways that help people thrive. WELL v2 is the latest version of its popular WELL Building Standard, and the WELL Community Standard pilot is a district scale rating system that sets a new global benchmark for healthy communities. WELL is focused exclusively on the ways that buildings and communities, and everything in them, can improve our comfort, drive better choices, and generally enhance, not compromise, our health and wellness. IWBI mobilizes the wellness community through management of the WELL AP credential, the pursuit of applicable research, the development of educational resources, and advocacy for policies that promote health and wellness everywhere. IWBI is a participant of the United Nations Global Compact, the world’s largest corporate citizenship initiative, and helps companies advance the UN Sustainable Development Goals (SDGs) through the use of WELL. More information on WELL can be found here .

International WELL Building Institute, IWBI, the WELL Building Standard, WELL v2, WELL Certified, WELL AP, WELL, WELL Portfolio, The WELL Conference, the WELL Community Standard and others, and their related logos are trademarks or certification marks of International WELL Building Institute pbc in the United States and other countries.

Social Media:

https://facebook.com/wellbuildinginstitute/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products30.6.2026 18:19:00 CEST | Press release

FDA’s decision makes ZYN the first nicotine pouch product to receive MRTP orders authorizing reduced-risk claims versus cigarettes Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch products. These are the first MRTP orders granted for nicotine pouches, allowing PMI U.S. to market the following claim for the authorized ZYN products: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.” “FDA’s decision is an important moment for the more than 45 million legal-age nicotine consumers in America,” saidStacey Kennedy, PMI U.S. CEO. “Today’s news ensures these adultshave access to accurate, science-based information, including FDA-authorized evidence that switching from cigarettes to ZYN reduces the risk of smoking-related diseases like heart disease

Caidya Announces Strategic Combination with Simbec-Orion Bridging Early Scientific Insight and Global Clinical Execution30.6.2026 17:00:00 CEST | Press release

Caidya today announced a strategic combination with Simbec-Orion designed to close the divide between early scientific insight and global clinical execution. The combination of Caidya and Simbec-Orion creates a differentiated specialty clinical CRO platform that enables programs to scale, maintaining focus, speed, and accountability. The strategic combination brings together complementary strengths to create a more complete development partner for innovative biopharma companies. With established operations across Europe, the Americas, APAC, and China, the combined organization provides meaningful expertise and execution capabilities in the regions that matter most. Simbec-Orion brings early-phase clinical pharmacology capabilities alongside deep therapeutic expertise for later stage complex oncology and rare disease trials, helping sponsors shape critical decisions early in the development lifecycle. Together, the organizations strengthen their ability to support complex, cross-border

Archer® Proves Purpose-Built AI Beats General-Purpose LLMs on Regulatory Change Management: 95% Verified Accuracy, 80x Faster, 92% Lower Cost30.6.2026 16:13:00 CEST | Press release

In a head-to-head benchmark, a leading general-purpose LLM was confidently wrong 35% of the time on regulatory dates. Archer Evolv™ shipped zero errors. For enterprises deploying AI in compliance, a wrong date is a missed deadline. The more dangerous failure is a wrong answer the model returns with high confidence, one that flows silently into a compliance calendar and is only discovered after the window has passed. Archer® today released results showing purpose-built AI beats a general-purpose large language model (LLM) on regulatory work, and it’s not close. This head-to-head test compared Archer’s purpose-built, vertical-specific AI and proprietary data sets against a leading general-purpose LLM, on a core compliance task: determining the publication, effective and comment-close dates of regulatory documents across six jurisdictions. General-purpose models are a genuine breakthrough, and this is no referendum on their quality. The question Archer set out to answer is narrower and mo

Altasciences Supports Key Development Milestone for Steel Therapeutics’ Lead Therapeutic Candidate, Fizurex™30.6.2026 16:08:00 CEST | Press release

Altasciences, a leading drug development organization, today announced a significant milestone in the development of Steel Therapeutics, Inc.’s pivotal toxicology study for its lead product candidate, Fizurex™, for the treatment of anal fissures. The successful completion of the study plays a significant role in the advancement of Fizurex™ toward first-in-human trials. The GLP-compliant study demonstrated a favorable safety profile, which has advanced Steel Therapeutics' plans to submit an Investigational New Drug (IND) application for Fizurex™ to the FDA in Q3 2026. Fizurex™, a patent-pending, single-use topical wipe, was designed to provide a standardized, accessible treatment option for a painful and often undertreated medical condition. The product builds on years of use through compounding pharmacy prescriptions and is now advancing toward clinical development and regulatory review. "We are proud to have supported Steel Therapeutics with the generation of the high-quality safety d

Interactive Brokers Expands Access to Korean Equities with Launch of Nextrade ATS30.6.2026 16:00:00 CEST | Press release

IB SmartRouting℠ Routes Orders to the Best Available Price Between KRX and Nextrade Interactive Brokers (Nasdaq: IBKR), an automated global broker, today announced the launch of select Korean equities through Nextrade, South Korea's first Alternative Trading System (ATS). The addition of Nextrade builds on Interactive Brokers' earlier launch of the Korea Exchange (KRX), through which it became the first major US-based broker to provide global investors with direct access to Korean equities. Clients trading on Nextrade benefit from significantly extended trading hours and access to additional liquidity. Interactive Brokers has enabled IB SmartRouting℠ across both the Korea Exchange (KRX) and Nextrade, automatically routing orders to the venue offering the best price. This helps clients achieve best execution while providing greater flexibility and more opportunities to participate in one of Asia's most dynamic equity markets. Korea's equity market ranks among the top global exchanges by

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye